Cargando…
Antileishmanial Activity of the Estrogen Receptor Modulator Raloxifene
BACKGROUND: The treatment of leishmaniasis relies mostly on parenteral drugs with potentially serious adverse effects. Additionally, parasite resistance in the treatment of leishmaniasis has been demonstrated for the majority of drugs available, making the search for more effective and less toxic dr...
Autores principales: | Reimão, Juliana Q., Miguel, Danilo C., Taniwaki, Noemi N., Trinconi, Cristiana T., Yokoyama-Yasunaka, Jenicer K. U., Uliana, Silvia R. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014391/ https://www.ncbi.nlm.nih.gov/pubmed/24810565 http://dx.doi.org/10.1371/journal.pntd.0002842 |
Ejemplares similares
-
Leishmania is not prone to develop resistance to tamoxifen
por: Coelho, Adriano C., et al.
Publicado: (2015) -
Tamoxifen Is Effective in the Treatment of Leishmania amazonensis Infections in Mice
por: Miguel, Danilo C., et al.
Publicado: (2008) -
A Luciferase-Expressing Leishmania braziliensis Line That Leads to Sustained Skin Lesions in BALB/c Mice and Allows Monitoring of Miltefosine Treatment Outcome
por: Coelho, Adriano C., et al.
Publicado: (2016) -
Generation of Luciferase-Expressing Leishmania infantum chagasi and Assessment of Miltefosine Efficacy in Infected Hamsters through Bioimaging
por: Reimão, Juliana Q., et al.
Publicado: (2015) -
The Selective Estrogen Receptor Modulator Raloxifene Inhibits Neutrophil Extracellular Trap Formation
por: Flores, Roxana, et al.
Publicado: (2016)